Literature DB >> 32570110

Hyperuricemia is associated with sympathovagal imbalance in older adults.

R S Passos1, Ícaro J S Ribeiro1, Ivna Vidal Freire1, Mauro Fernandes Teles1, Ramon Alves Pires1, Ludmila Schettino1, Alinne Alves Oliveira1, Cezar Augusto Casotti2, Rafael Pereira3.   

Abstract

PURPOSE: This study aimed to compare heart rate variability (HRV) parameters obtained through symbolic analysis (SA), between older adults with and without hyperuricemia.
METHODS: This is a cross-sectional study including 202 community-dwelling old adults, which was clinically stratified as with or without hyperuricemia, according to the cutoff point of serum uric acid ≥ 6 mg/dL for women and ≥ 7 mg/dL for men. Successive RR intervals were recorded along 5 min and analyzed with SA method. 0 V%, 1 V% and 2 V% patterns were quantified and compared between groups. Comparisons were carried out through parametric or nonparametric tests, according to the data distribution characteristics, evaluated by Kolmogorov-Smirnov test. The significance level was set as p ≤ 0.05 for all statistical procedures.
RESULTS: The prevalence of hyperuricemia was 67.8 %, and the hyperuricemic older adults exhibited significant higher values for V0% and lower values for V2% parameters when compared to normouricemic older adults.
CONCLUSION: These results suggesting a sympathovagal imbalance in hyperuricemic older adults, characterized by greater sympathetic predominance (0 V%) and lower vagal modulation (2 V%) at rest conditions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Oxidative stress; Sympathovagal balance; Uric acid

Mesh:

Substances:

Year:  2020        PMID: 32570110     DOI: 10.1016/j.archger.2020.104132

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  1 in total

Review 1.  Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.

Authors:  Linggen Gao; Bin Wang; Ying Pan; Yan Lu; Rui Cheng
Journal:  Clin Cardiol       Date:  2021-05-20       Impact factor: 3.287

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.